ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Cost watchdog ICER lays out plans to scrutinize pharma's costliest price hikes fiercepharma
January 22, 2019The Institute for Clinical and Economic Review has been a thorn in pharma’s side for years,?with its reviews?often concluding drug launches?are priced too high. Now, the pain for pharma could spread. -
Cost watchdog ICER lays out plans to scrutinize pharma's costliest price hikes fiercepharma
January 22, 2019The Institute for Clinical and Economic Review has been a thorn in pharma’s side for years,?with its reviews?often concluding drug launches?are priced too high. Now, the pain for pharma could spread.
Pharma Sources Insight January 2025
